You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Baxter

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc. (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-09-25
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Parties OXFORD NANOPORE TECHNOLOGIES, INC.; OXFORD NANOPORE TECHNOLOGIES, LTD.; PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Patents 10,092,534; 10,098,893; 10,167,486; 10,201,517; 10,201,615; 10,206,893; 10,206,910; 10,212,939; 10,214,509; 10,214,577; 10,214,732; 10,246,682; 10,264,777; 10,292,939; 10,294,488; 10,412,941; 10,426,777; 10,456,472; 10,456,478; 10,456,479; 10,456,646; 10,460,831; 10,463,598; 10,463,627; 10,463,656; 10,463,754; 10,464,890; 10,471,140; 10,472,424; 10,478,472; 10,478,497; 10,479,890; 10,487,145; 10,517,507; 10,517,865; 10,526,381; 10,526,631; 10,543,321; 10,561,651; 10,570,457; 10,571,424; 10,597,411; 10,631,974; 6,124,486; 6,214,865; 6,302,897; 6,316,462; 6,316,475; 6,322,460; 6,322,843; 6,350,867; 6,428,785; 6,458,462; 6,468,472; 6,468,559; 6,468,576; 6,475,468; 6,479,512; 6,509,514; 6,514,529; 6,528,321; 6,534,734; 6,559,322; 6,562,873; 6,572,497; 6,572,873; 6,615,471; 6,656,919; 6,737,246; 6,849,427; 6,858,650; 6,864,264; 6,869,939; 6,911,214; 6,911,461; 6,911,464; 6,941,326; 6,949,571; 7,153,473; 7,153,889; 7,201,920; 7,223,837; 7,249,802; 7,267,743; 7,276,491; 7,302,949; 7,323,463; 7,400,631; 7,425,326; 7,425,333; 7,456,207; 7,458,372; 7,462,472; 7,468,372; 7,468,390; 7,473,543; 7,476,652; 7,488,486; 7,491,403; 7,491,725; 7,491,858; 7,491,869; 7,510,873; 7,527,974; 7,572,448; 7,572,920; 7,582,321; 7,582,658; 7,582,694; 7,598,207; 7,598,271; 7,615,223; 7,650,737; 7,658,888; 7,658,914; 7,682,802; 7,713,570; 7,713,914; 7,713,929; 7,717,889; 7,732,615; 7,737,165; 7,745,460; 7,754,271; 7,754,424; 7,754,479; 7,763,582; 7,785,627; 7,785,637; 7,829,300; 7,829,665; 7,858,139; 7,858,789; 7,863,249; 7,863,426; 7,867,529; 7,873,479; 7,888,469; 7,910,576; 7,914,785; 7,915,229; 7,915,275; 7,915,460; 7,915,479; 7,919,264; 7,919,322; 7,919,461; 7,919,598; 7,939,249; 7,939,323; 7,964,202; 7,964,212; 8,123,476; 8,123,789; 8,152,658; 8,155,737; 8,206,448; 8,206,757; 8,246,980; 8,318,802; 8,318,920; 8,323,615; 8,338,427; 8,338,428; 8,338,479; 8,338,486; 8,361,466; 8,361,471; 8,361,763; 8,372,615; 8,412,461; 8,412,462; 8,425,462; 8,426,141; 8,426,391; 8,426,462; 8,460,381; 8,461,140; 8,461,321; 8,461,427; 8,475,831; 8,476,206; 8,476,425; 8,481,598; 8,486,403; 8,486,456; 8,486,469; 8,486,975; 8,491,777; 8,507,646; 8,512,717; 8,574,858; 8,574,889; 8,597,713; 8,598,412; 8,637,457; 8,637,458; 8,637,512; 8,652,476; 8,652,479; 8,658,615; 8,658,694; 8,754,123; 8,785,426; 8,785,428; 8,785,456; 8,785,597; 8,802,411; 8,802,717; 8,829,165; 8,829,275; 8,858,939; 8,858,964; 8,864,487; 8,865,461; 8,865,949; 8,865,953; 8,889,831; 8,911,570; 8,915,888; 8,915,889; 8,974,767; 8,974,802; 8,980,300; 8,992,486; 8,992,975; 9,145,426; 9,155,763; 9,206,390; 9,206,428; 9,241,869; 9,241,980; 9,271,941; 9,271,949; 9,308,426; 9,321,754; 9,370,802; 9,427,448; 9,427,458; 9,427,477; 9,427,479; 9,427,480; 9,427,615; 9,428,543; 9,428,582; 9,458,411; 9,458,466; 9,464,139; 9,464,326; 9,468,598; 9,480,652; 9,480,694; 9,481,627; 9,486,412; 9,486,424; 9,486,426; 9,486,461; 9,486,682; 9,487,767; 9,487,830; 9,488,665; 9,492,486; 9,526,725; 9,526,737; 9,527,858; 9,534,651; 9,561,204; 9,561,229; 9,571,890; 9,572,867; 9,572,897; 9,577,864; 9,581,598; 9,597,571; 9,598,400; 9,598,486; 9,598,734; 9,651,562; 9,682,145; 9,700,486; 9,700,514; 9,700,597; 9,713,543; 9,713,572; 9,713,637; 9,717,763; 9,731,869; 9,732,326; 9,737,488; 9,737,491; 9,737,554; 9,737,600; 9,737,777; 9,757,418; 9,757,458; 9,757,468; 9,757,471; 9,757,476; 9,757,477; 9,757,514; 9,763,920; 9,763,941; 9,789,204; 9,802,949; 9,829,487; 9,867,889; 9,873,843; 9,873,889; 9,914,757; 9,914,785; 9,914,802; 9,949,480; 9,974,302; 9,974,745; 9,974,770; 9,975,919; 9,980,488; 9,980,974
Attorneys Anna E. Dwyer; Brian E. Farnan; Derek C. Walter; Edward R. Reines; Jack B. Blumenfeld; Jeffrey J. Lyons; Jennifer Ying; Maryellen Noreika; Michael J. Farnan; Shawn Chi; Stephen Bosco
Firms Baker & Hostetler; Farnan LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc.
Biologic Drugs cited in Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-04-29 527 Brief - Opening Brief in Support sidebar that he was walking a fine line. D.I. 486 at 167:19. This magnified the prejudice of ONT’s argument…underlying facts necessary to determine that the ’010 patent is invalid for lack of enablement.” …compete by filing patents to block, to tangle up, to exclude and to fool.”), 1622:10-11 (“It’s not about…approach had been patented long before the ’056 patent and that ONT touts those patents on its website …about patents, and this is a patent case, and as you saw in the video earlier today, a patent is External link to document
2020-04-29 529 Brief - Opening Brief in Support Infringing the ’400 or ’323 Patent. ............................................. 10 B. Alternatively…Performed in the United States.10 Independent claim 1 of the ’056 Patent is a method claim and recites…consistently referred to the ’056 Patent as the “two-step enzyme” 10 During trial, Oxford moved…asserted patents invalid, but also that three of the patents—the ’400, ’323, and ’056 Patents—were infringed…Concepts v. U.S. Healthcare, Inc., 140 F.3d 494, 534 (3d Cir. 1998) (where jury instruction invited External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
AstraZeneca
Express Scripts
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.